[On the treatment of combined banal infections].
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000996:Antitussive Agents / Q000627:therapeutic use; D001991:Bronchitis / Q000188:drug therapy; D002110:Caffeine / Q000627:therapeutic use; D004155:Diphenhydramine / Q000627:therapeutic use; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010615:Phenacetin / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012220:Rhinitis / Q000188:drug therapy; D012457:Salicylamides / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000996:Antitussive Agents; D006634:Histamine H1 Antagonists; D012457:Salicylamides; D014662:Vasoconstrictor Agents; D002110:Caffeine; D004155:Diphenhydramine; D010615:Phenacetin
Zur Behandlung kombinierter banaler Infekte.